![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Location preferences for accessing long-acting injectable pre-exposure prophylaxis (LA-PrEP) among men who have sex with men (MSM) in the U.S currently using daily-oral PrEP
|
|
|
AIDS 2024, the 25th International AIDS Conference
Jennifer L. Glick, PhD, MPH1,2; Danielle F. Nestadt PhD, MPH, MSW2; Travis Sanchez, DVM, MPH3, Kevin Li, MPH2; Marissa Hannah, MPH3; M Keith Rawlings, MD4; Supriya Sarkar, PhD, MPH4; Vani Vannappagari, PhD, MPH, MBBS4
1 Louisiana State University Health Science Center, School of Public Health, New Orleans, LA, USA ; 2 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; 3 Emory Rollins School of Public Health, Atlanta, Georgia, USA; 4 ViiV Healthcare, Durham, North Carolina, USA
![0801241](../images/080124/080124-3/0801241.gif)
![0801242](../images/080124/080124-3/0801242.gif)
![0801243](../images/080124/080124-3/0801243.gif)
![0801244](../images/080124/080124-3/0801244.gif)
![0801245](../images/080124/080124-3/0801245.gif)
![0801246](../images/080124/080124-3/0801246.gif)
![0801247](../images/080124/080124-3/0801247.gif)
![0801248](../images/080124/080124-3/0801248.gif)
![0801249](../images/080124/080124-3/0801249.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|